Image_2_Phenotypic and Functional Profiles of Antigen-Specific CD4+ and CD8+ T Cells Associated With Infection Control in Patients With Cutaneous Leishmaniasis.tif
The host immunological response is a key factor determining the pathogenesis of cutaneous leishmaniasis. It is known that a Th1 cellular response is associated with infection control and that antigen-specific memory T cells are necessary for the development of a rapid and strong protective cellular response. The present manuscript reports the analysis of the functional and phenotypic profiles of antigen-specific CD4+ and CD8+ T cells from patients cured of cutaneous leishmaniasis (CL), patients with an active process of cutaneous leishmaniasis, asymptomatic individuals with a positive Montenegro test and healthy donors (HD). Peripheral blood mononuclear cells (PBMCs) from the patients exhibited a lymphoproliferative capacity after stimulation with total soluble protein from either Leishmania panamensis (SLpA) or Leishmania infantum (SLiA) or with a recombinant paraflagellar rod protein-1 (rPFR1). Higher frequencies of antigen-specific TNAIVE cells, mainly following stimulation with rPFR1, were observed in asymptomatic and cured patients than in patients with active cutaneous leishmaniasis, while T cells from patients with active cutaneous leishmaniasis showed a higher percentage of effector memory T cells (TEM for CD4+ T cells and TEMRA for CD8+ T cells). The amount of antigen-specific CD57+/CD8+ TEMRA cells in patients with active cutaneous leishmaniasis was higher than that in cured patients and asymptomatic subjects. Regarding functionality, a more robust multifunctional CD8+ T cell response was detected in cured patients than in those with active cutaneous leishmaniasis. Moreover, cured patients showed a significant increase in the frequency of cells expressing a Th1-type cytotoxic production profile (IFN-γ+/granzyme-B/+perforin+). Patients with an active leishmaniosis process had a significantly higher frequency of CD8+ T cells expressing the inhibitory CD160 and 2B4 receptors than did cured patients. The expression profile observed in cured patients could be indicative of an imbalance toward a CD8+ Th1 response, which could be associated with infection control; consequently, the determination of this profile could be a useful tool for facilitating the clinical follow-up of patients with cutaneous leishmaniasis. The results also suggest a possible exhaustion process of CD8+ T cells associated with the evolution of Leishmania infection.
History
References
- https://doi.org//10.1371/journal.pone.0035671
- https://doi.org//10.1016/j.celrep.2014.06.012
- https://doi.org//10.1002/eji.200939451
- https://doi.org//10.3389/fimmu.2018.01021
- https://doi.org//10.1016/0248-4900(88)90056-1
- https://doi.org//10.1128/IAI.02404-14
- https://doi.org//10.1002/eji.201040384
- https://doi.org//10.1038/35065118
- https://doi.org//10.1189/jlb.0208107
- https://doi.org//10.1016/j.imbio.2016.03.007
- https://doi.org//10.3389/fpubh.2014.00165
- https://doi.org//10.1111/j.1365-2133.2005.06647.x
- https://doi.org//10.1128/CDLI.9.2.251-256.2002
- https://doi.org//10.3389/fimmu.2016.00151
- https://doi.org//10.1016/j.trstmh.2006.02.014
- https://doi.org//10.1111/cei.12798
- https://doi.org//10.1007/s40257-015-0114-z
- https://doi.org//10.1371/journal.pone.0122115
- https://doi.org//10.1016/j.molimm.2012.05.021
- https://doi.org//10.4049/jimmunol.1301810
- https://doi.org//10.1111/j.1365-3024.2009.01125.x
- https://doi.org//10.1086/600109
- https://doi.org//10.1371/journal.pntd.0000512
- https://doi.org//10.1086/340261
- https://doi.org//10.1093/infdis/jit401
- https://doi.org//10.1016/j.pt.2012.07.001
- https://doi.org//10.1016/j.cellimm.2016.07.010
- https://doi.org//10.1371/journal.pntd.0000871
- https://doi.org//10.1371/journal.pntd.0001204
- https://doi.org//10.1371/journal.ppat.1000431
- https://doi.org//10.1016/j.virol.2014.12.033
- https://doi.org//10.1038/nrmicro2608
- https://doi.org//10.1007/s10875-012-9788-7
- https://doi.org//10.1016/j.micinf.2012.02.006
- https://doi.org//10.1128/AAC.04298-14
- https://doi.org//10.1371/journal.pntd.0004178
- https://doi.org//10.4049/jimmunol.1500459
- https://doi.org//10.1186/s12917-017-1224-z
- https://doi.org//10.1002/eji.200535458
- https://doi.org//10.4049/jimmunol.1602095
- https://doi.org//10.1086/382135
- https://doi.org//10.1128/IAI.71.6.3165-3171.2003
- https://doi.org//10.7705/biomedica.v28i4.66
- https://doi.org//10.1016/j.vaccine.2006.07.006
- https://doi.org//10.4049/jimmunol.1202537
- https://doi.org//10.1155/2014/636039
- https://doi.org//10.1371/journal.ppat.1003504
- https://doi.org//10.1007/s12026-008-8016-2
- https://doi.org//10.1590/S0074-02762007000100013
- https://doi.org//10.1038/srep28266
- https://doi.org//10.1016/S0035-9203(02)90071-4
- https://doi.org//10.1371/journal.pntd.0002567
- https://doi.org//10.1111/j.1365-3024.2007.00991.x
- https://doi.org//10.1038/nri933
- https://doi.org//10.1146/annurev.immunol.22.012703.104702
- https://doi.org//10.1038/jid.2013.4
- https://doi.org//10.1111/j.1365-3024.2009.01116.x
- https://doi.org//10.1084/jem.20030159
- https://doi.org//10.4049/jimmunol.166.6.4012
- https://doi.org//10.3390/ijms18081742
- https://doi.org//10.1038/nm1108